TY - JOUR
T1 - Charting the Path Forward
T2 - Development, Goals and Initiatives of the 2019 Infectious Diseases of America Strategic Plan
AU - Sears, Cynthia L.
AU - File, Thomas M.
AU - Alexander, Barbara D.
AU - McQuillen, Daniel P.
AU - MacIntyre, Ann T.
AU - Allen, Upton D.
AU - Colasanti, Jonathan A.
AU - Siddiqui, Javeed
AU - Reveles, Kelly R.
AU - Busky, Chris
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/11/27
Y1 - 2019/11/27
N2 - In October 2018, the Infectious Diseases Society of America (IDSA) Board of Directors (BOD) decided to develop a 2019 IDSA Strategic Plan. The IDSA BOD has invested in strategic planning at regular intervals as part of an ongoing process to review and to renew the vision and direction of IDSA. Herein, the 2018-2019 strategic planning process and outcomes are described. The 2019 IDSA Strategic Plan presents 4 key initiatives: (1) optimize the development, dissemination, and adoption of timely and relevant ID guidance and guidelines that improve the outcomes of clinical care; (2) quantify, communicate, and advocate for the value of ID physicians to increase professional fulfillment and compensation; (3) facilitate the growth and development of the ID workforce to meet emerging scientific, clinical, and leadership needs; and (4) develop and position a new tool to serve as the leading US benchmark to measure and drive national progress on antimicrobial resistance. The BOD looks forward to developing, implementing, assessing, and advancing the 2019 IDSA Strategic Plan working with member volunteers, Society partners, and IDSA staff.
AB - In October 2018, the Infectious Diseases Society of America (IDSA) Board of Directors (BOD) decided to develop a 2019 IDSA Strategic Plan. The IDSA BOD has invested in strategic planning at regular intervals as part of an ongoing process to review and to renew the vision and direction of IDSA. Herein, the 2018-2019 strategic planning process and outcomes are described. The 2019 IDSA Strategic Plan presents 4 key initiatives: (1) optimize the development, dissemination, and adoption of timely and relevant ID guidance and guidelines that improve the outcomes of clinical care; (2) quantify, communicate, and advocate for the value of ID physicians to increase professional fulfillment and compensation; (3) facilitate the growth and development of the ID workforce to meet emerging scientific, clinical, and leadership needs; and (4) develop and position a new tool to serve as the leading US benchmark to measure and drive national progress on antimicrobial resistance. The BOD looks forward to developing, implementing, assessing, and advancing the 2019 IDSA Strategic Plan working with member volunteers, Society partners, and IDSA staff.
KW - ID workforce
KW - IDSA
KW - antimicrobial resistance
KW - guidelines
KW - strategic plan
UR - http://www.scopus.com/inward/record.url?scp=85075813662&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075813662&partnerID=8YFLogxK
U2 - 10.1093/cid/ciz1040
DO - 10.1093/cid/ciz1040
M3 - Article
C2 - 31620782
AN - SCOPUS:85075813662
SN - 1058-4838
VL - 69
SP - e1-e7
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 12
ER -